Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-23 4:09 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 4,327,622 9.8% | 458,230 (+11.84%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 3,869,392 8.8% | 343,935 (+9.76%) | View |
| 2022-02-10 5:29 pm Sale | 13G | DARIOHEALTH CORP COM DRIO | Soleus Capital LLC | 0 0% | -401,606 (Position Closed) | View |
| 2022-02-10 5:27 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 3,525,457 8.01% | 3,525,457 (New Position) | View |
| 2021-02-12 4:01 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 3,474,658 9.99% | 630,471 (+22.17%) | View |
| 2020-08-03 12:56 pm Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 2,844,187 9.99% | 721,214 (+33.97%) | View |
| 2020-07-31 5:20 pm Purchase | 13G | DARIOHEALTH CORP COM DRIO | Soleus Capital LLC | 401,606 5.62% | 401,606 (New Position) | View |
| 2020-02-12 4:03 pm Sale | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 2,122,973 9.99% | -15,289 (-0.72%) | View |
| 2019-08-29 09:44 am Purchase | 13G | ESSA PHARMA INC EPIX | Soleus Capital LLC | 2,138,262 9.99% | 2,138,262 (New Position) | View |